Relief Therapeutics Holding SA (SWX: RLF)
Switzerland
· Delayed Price · Currency is CHF
3.890
-0.470 (-10.78%)
Dec 3, 2024, 12:23 PM CET
RLF Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 52 | 25 | 132 | 274 | 873 | 2 | |
Market Cap Growth | -56.37% | -81.09% | -51.90% | -68.59% | 41215.19% | -80.54% | |
Enterprise Value | 44 | 17 | 106 | 263 | 874 | 3 | |
Last Close Price | 4.18 | 1.99 | 12.00 | 24.88 | 107.60 | 0.40 | |
PS Ratio | 6.07 | 4.14 | 21.70 | 82.61 | - | - | |
PB Ratio | 1.07 | 0.48 | 0.91 | 1.51 | 13.03 | 0.15 | |
P/TBV Ratio | - | - | - | - | 24.10 | - | |
EV/Sales Ratio | 5.13 | 2.77 | 17.46 | 79.33 | - | - | |
Debt / Equity Ratio | 0.05 | 0.08 | 0.03 | 0.02 | 0.01 | 0.12 | |
Asset Turnover | 0.09 | 0.05 | 0.03 | 0.02 | - | - | |
Inventory Turnover | 6.56 | 4.90 | 4.05 | 3.84 | - | - | |
Quick Ratio | 2.45 | 2.52 | 2.01 | 2.41 | 5.73 | 0.08 | |
Current Ratio | 3.09 | 2.65 | 2.11 | 2.79 | 7.00 | 0.09 | |
Return on Equity (ROE) | -64.38% | -99.35% | -31.07% | -27.92% | -19.25% | -41.93% | |
Return on Assets (ROA) | -7.83% | -9.35% | -9.92% | -12.98% | -24.72% | -2.14% | |
Return on Capital (ROIC) | -10.23% | -12.02% | -13.02% | -16.87% | -28.82% | -3.08% | |
Earnings Yield | -88.58% | -393.42% | -38.49% | -12.65% | -0.90% | -352.90% | |
FCF Yield | -19.82% | -72.36% | -18.31% | -13.02% | -2.09% | -34.44% | |
Buyback Yield / Dilution | -14.39% | -11.18% | -17.67% | -48.89% | -14.71% | -2.62% | |
Total Shareholder Return | -14.39% | -11.18% | -17.67% | -48.89% | -14.71% | -2.62% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.